P. B. McCulloch

951 total citations
20 papers, 749 citations indexed

About

P. B. McCulloch is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, P. B. McCulloch has authored 20 papers receiving a total of 749 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Immunology. Recurrent topics in P. B. McCulloch's work include Immunotherapy and Immune Responses (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Cutaneous Melanoma Detection and Management (4 papers). P. B. McCulloch is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Cutaneous Melanoma Detection and Management (4 papers). P. B. McCulloch collaborates with scholars based in Canada, Switzerland and Kenya. P. B. McCulloch's co-authors include P. B. Dent, Shuen‐Kuei Liao, V. Basrur, Rebecca S.R. McDermot, Michael Lipa, Mark N. Levine, Bhavani D. Nair, C. Shun Wong, P J Corbett and Roy M. Clark and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Internal Medicine and JNCI Journal of the National Cancer Institute.

In The Last Decade

P. B. McCulloch

19 papers receiving 693 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. B. McCulloch Canada 9 354 323 181 170 150 20 749
Catherine Curran Ireland 18 505 1.4× 592 1.8× 169 0.9× 514 3.0× 52 0.3× 38 1.2k
Michael J. Burdick United States 9 192 0.5× 207 0.6× 54 0.3× 434 2.6× 39 0.3× 12 792
C. A. Martindale United Kingdom 11 147 0.4× 163 0.5× 51 0.3× 234 1.4× 24 0.2× 15 531
Kazutoshi Ota Japan 12 288 0.8× 116 0.4× 32 0.2× 219 1.3× 106 0.7× 17 622
Daphne Morrell United States 8 579 1.6× 568 1.8× 289 1.6× 1.0k 6.2× 31 0.2× 13 1.6k
Mina Takahashi Japan 12 193 0.5× 137 0.4× 104 0.6× 407 2.4× 33 0.2× 48 719
M Schena Italy 17 225 0.6× 49 0.2× 142 0.8× 245 1.4× 277 1.8× 34 893
Brent F.G. Treiger United States 10 166 0.5× 147 0.5× 129 0.7× 329 1.9× 59 0.4× 11 763
Robert Aiken United States 14 193 0.5× 119 0.4× 25 0.1× 224 1.3× 120 0.8× 36 575
D. H. Rutgers Netherlands 12 147 0.4× 91 0.3× 23 0.1× 248 1.5× 23 0.2× 17 502

Countries citing papers authored by P. B. McCulloch

Since Specialization
Citations

This map shows the geographic impact of P. B. McCulloch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. B. McCulloch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. B. McCulloch more than expected).

Fields of papers citing papers by P. B. McCulloch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. B. McCulloch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. B. McCulloch. The network helps show where P. B. McCulloch may publish in the future.

Co-authorship network of co-authors of P. B. McCulloch

This figure shows the co-authorship network connecting the top 25 collaborators of P. B. McCulloch. A scholar is included among the top collaborators of P. B. McCulloch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. B. McCulloch. P. B. McCulloch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Clark, Roy M., P. B. McCulloch, Mark N. Levine, et al.. (1992). Randomized Clinical Trial to Assess the Effectiveness of Breast Irradiation Following Lumpectomy and Axillary Disection for Node-Negative Breast Cancer. JNCI Journal of the National Cancer Institute. 84(9). 683–689. 311 indexed citations
3.
Witelson, Sandra F. & P. B. McCulloch. (1991). Premortem and Postmortem Measurement to Study Structure With Function: A Human Brain Collection. Schizophrenia Bulletin. 17(4). 583–591. 29 indexed citations
4.
Ginsburg, A D, et al.. (1989). Systemic adjuvant therapy for node-negative breast cancer.. PubMed. 141(5). 381–7. 3 indexed citations
5.
Clark, David A., P. B. McCulloch, Shuen‐Kuei Liao, P. B. Dent, & A Fuks. (1984). Sensitivity of Human Carcinoma Cell Lines to Lysis by Blood Natural Killer Cells Correlating With Surface Expression of Carcinoembryonic Antigen<xref ref-type="fn" rid="FN2">2</xref>. JNCI Journal of the National Cancer Institute. 72(3). 505–12. 10 indexed citations
6.
Dent, Peter B., et al.. (1982). Absence of melanoma specificity in the reactivity of melanoma patients' sera with cultured allogeneic melanoma cell lines. Cancer. 49(10). 2043–2048. 3 indexed citations
7.
Dent, P. B., et al.. (1982). Heterogeneity of melanoma-associated antigens detected by sera from patients receiving adjuvant allogeneic tumor vaccine immunotherapy. Clinical Immunology and Immunopathology. 23(2). 379–391. 7 indexed citations
8.
Williams, Christopher Kwesi O., Graham F. Pineo, Alexander Gallus, & P. B. McCulloch. (1980). The relevance of platelet and fibrinogen kinetics and coagulation studies to extent of disease and performance status in patients with adenocarcinoma. Medical and Pediatric Oncology. 8(4). 367–374. 6 indexed citations
9.
Dent, Peter B., Jacques Louis, P. B. McCulloch, Charles W. Dunnett, & Jean‐Charles Cerottini. (1980). Correlation of elevated C1q binding activity and carcinoembryonic antigen levels with clinical features and prognosis in bronchogenic carcinoma. Cancer. 45(1). 130–136. 21 indexed citations
10.
Dent, Peter B. & P. B. McCulloch. (1980). Detection of recurrent metastases using tumor associated serum markers: Validity of results. European Journal of Cancer (1965). 16(7). 963–963. 1 indexed citations
11.
Dent, P. B., Shuen‐Kuei Liao, P. B. McCulloch, M. A. Blajchman, & J. Macnamara. (1978). Characterization of human malignant melanoma cell lines. III. Membrane immunofluorescence reactivity with sera from patients with melanoma. Cancer Immunology Immunotherapy. 3(4). 4 indexed citations
12.
Dent, Peter B., et al.. (1978). Measurement of carcinoembryonic antigen in patients with bronchogenic carcinoma. Cancer. 42(S3). 1484–1491. 71 indexed citations
13.
McCulloch, P. B., et al.. (1977). Recurrent malignant melanoma: effect of adjuvant immunotherapy on survival.. PubMed. 117(1). 33–6. 7 indexed citations
14.
McCulloch, P. B., et al.. (1976). Common and individually specific chromosomal characteristics of cultured human melanoma.. PubMed. 36(2 Pt 1). 398–404. 37 indexed citations
15.
Liao, Shuen‐Kuei, P. B. Dent, & P. B. McCulloch. (1976). Cellular morphology of human malignant melanoma in primary culture. In Vitro Cellular & Developmental Biology - Plant. 12(9). 654–657. 8 indexed citations
16.
Dent, P. B., et al.. (1975). Cellular immunocompetence in melanoma: effect of extent of disease and immunotherapy. British Journal of Cancer. 32(3). 323–330. 31 indexed citations
17.
Liao, Shuen‐Kuei, P. B. Dent, & P. B. McCulloch. (1975). Characterization of Human Malignant Melanoma Cell Lines. I. Morphology and Growth Characteristics in Culture<xref ref-type="fn" rid="fn2"><sup>2</sup></xref>. JNCI Journal of the National Cancer Institute. 54(5). 1037–44. 66 indexed citations
18.
Singal, D. P., et al.. (1974). HL-A ANTIGENS IN MALIGNANT MELANOMA. Transplantation. 18(2). 186–186. 8 indexed citations
19.
Barr, RD, et al.. (1972). Acute Leukaemia in Kenya. Scottish Medical Journal. 17(10). 330–333. 5 indexed citations
20.
McCulloch, P. B.. (1971). The Immunology of Malignant Disease.. Annals of Internal Medicine. 74(5). 811–811. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026